News | April 05, 2009

Baylor Chooses Carestream Molecular Imaging’s Technology for In-Vivo Research

April 6, 2009 — Baylor College of Medicine (BCM) is using optical molecular imaging technology from Carestream Molecular Imaging to advance the study of diseases and therapies involving cancer, cardiovascular disease, infectious agents, inflammatory disease and other conditions.
The company’s KODAK In-Vivo Multispectral Imaging System FX is installed at BCM’s Frensley Center for Imaging Research, which uses imaging to support development of novel agents and other research tools used in the detection and treatment of diseases. Researchers apply the system to a wide variety of imaging techniques that combine optical and X-ray, as well as other modalities such as PET and SPECT isotopes.
“The KODAK Multispectral System combines optical, X-ray and nuclear imaging, allowing us to more precisely localize the molecular signals in vivo — based on the co-registered multi-imaging modalities,” said Shi Ke, M.D., technical director of the Frensley Center for Imaging Research, Baylor College of Medicine. “I believe optical molecular imaging has a bright future, because it will offer more target-specific agents in the light spectrum with accuracy and specificity for disease detection than current PET metabolic agents.
“Optical molecular imaging also delivers the ability to simultaneously test multiple disease markers. Since it usually takes 24 to 48 hours to get results from each test, this will greatly speed disease identification and allow treatment to begin more quickly,” said Dr. Ke.
The Frensley Center for Imaging Research emphasizes the combination of chemistry and biology research. Its mission is to serve the imaging research interests of the basic science and clinical faculty. It also focuses upon industrial collaboration with key device, drug, and imaging partners to bring imaging and therapy advances to the clinic and benefit patients.

For more information: http://mi.carestreamhealth.com

Related Content

NIH Study of Brain Energy Patterns Provides New Insights into Alcohol Effects

NIH scientists present a new method for combining measures of brain activity (left) and glucose consumption (right) to study regional specialization and to better understand the effects of alcohol on the human brain. Image courtesy of Ehsan Shokri-Kojori, Ph.D., of NIAAA.

News | Neuro Imaging | March 22, 2019
March 22, 2019 — Assessing the patterns of energy use and neuronal activity simultaneously in the human brain improve
Improving Molecular Imaging Using a Deep Learning Approach
News | Nuclear Imaging | March 21, 2019
Generating comprehensive molecular images of organs and tumors in living organisms can be performed at ultra-fast speed...
PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
Researchers Create New Method for Developing Cancer Imaging Isotopes

Prototype fluidic system for zirconium-89 purification. Image taken through a hot cell window at the Department of Radiology, University of Washington. Image courtesy of Matthew O’Hara, Pacific Northwest National Laboratory

News | Radiopharmaceuticals and Tracers | March 14, 2019
A team of researchers at the University of Washington announced they developed a new automated system for producing...
Siemens Healthineers Announces First U.S. Install of Biograph Vision PET/CT
News | PET-CT | March 06, 2019
Siemens Healthineers’ new Biograph Vision positron emission tomography/computed tomography (PET/CT) system has been...
ImaginAb Enrolls First Patient in Phase II PET Agent Clinical Trial
News | Radiopharmaceuticals and Tracers | January 30, 2019
ImaginAb Inc. announced the enrollment of the first patient in the Phase II clinical trial of the company’s CD8+ T Cell...
FDA Clears United Imaging Healthcare uExplorer Total-Body Scanner
Technology | PET-CT | January 23, 2019
January 23, 2019 — United Imaging Healthcare (United Imaging) announced U.S.
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Videos | SPECT-CT | December 12, 2018
This is a walk around of the new Spectrum Dynamics Veriton SPECT-CT nuclear imaging system introduced at the 2018 ...